A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients

Journal of Clinical Psychiatry

Volumn 61, Issue 8, 2000, Pages 559-568

  Newhouse, P A ^a   Krishnan, K R R ^a   Doraiswamy, P M ^a   Richter, E M ^a   Batzar, E D ^a   Clary, C M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DRUG METABOLITE; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TEMAZEPAM; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; GERIATRIC PATIENT; GERONTOPSYCHIATRY; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MENTAL DISEASE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0033849889     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0804     Document Type: Article

References (51)

1. Epidemiology of dysphoria and depression in an elderly population
2. Mood disorders
3. Functional psychiatric disorders in the elderly
4. Symptomatic depression in elderly medical outpatients, I: Prevalence, demography, and health service utilization
5. Depressive symptoms in relation to physical health and functioning in the elderly
6. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
7. Detection and treatment of major depression in older medically ill hospitalized patients
8. Discontinuation rates of SSRIs and tricyclic antidepressants: A meta-analysis and investigation of heterogeneity
9. Use of serotonin selective reuptake inhibitors in geriatric depression
10. A comparison of paroxetine, imipramine, and placebo in depressed outpatients
11. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression
12. The use and tolerability of fluoxetine in geropsychiatric inpatients
13. Fluoxetine in elderly patients: Is there cause for concern?
14. Getting a grip on agitation-psychotropic medications
15. The treatment of late-life depression
16. Clinical pharmacokinetics of selective serotonin reuptake inhibitors
17. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients
18. Recent pharmacokinetic advances in antidepressant therapy of the elderly
19. Cognitive processes in depression
20. The neuropsychology of depression in the elderly: A comparative study of normal aging and Alzheimer's disease
21. Predicting severity of depression in the elderly at 6 month follow-up: A neuropsychological study
22. Correlates of cognitive function scores in elderly outpatients
23. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline
24. The range of quality of life: Relevance to the treatment of depression in the elderly
25. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
26. A rating scale for depression
27. Development of a rating scale for primary depressive illness
28. Psychometric developments of the Hamilton scales: The spectrum of depression, dysthymia, and anxiety
29. A new depression scale designed to be sensitive to change
30. The assessment of anxiety states by rating
31. An inventory for measuring depression
32. Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure
33. Acquisition and retention of categorized material in normal aging and senile dementia
34. Short-term retention, learning, and retrieval from long-term memory
35. Automated gas chromatographic-electron capture assay for the selective serotonin reuptake blocker, sertaline
36. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography
37. Comparative efficacy of sertraline versus fluoxetine in elderly patients over age 70 with major depression
38. Citalopram versus fluoxetine: A double-blind controlled, multicentre, phase III clinical trial in patients with unipolar major depression in general practice
39. Citalopram and fluoxetine in major depression: Comparison of two clinical trials in a psychiatrist setting and in general practice
40. Paroxetine in the elderly depressed patient: Randomized comparison with fluoxetine of efficacy, cognitive, and behavioral effects
41. Clinically relevant pharmacology of selective serotonin reuptake inhibitors: An overview with emphasis on pharmacokinetics and effects on oxidative metabolism
42. Pharmacological treatment of depression in late life
43. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression
44. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression
45. Fluoxetine in elderly patients: Is there cause for concern?
46. Use of pattern analysis to identify true drug response: A replication